$249.99
AMI’s Specialty HUB Services/Patient Assistance Providers 2024-2025 report includes profiles of approximately 75 companies that provide a wide range of specialty pharmaceutical hub and patient assistance services.
Hub and Patient Assistance Services are composed of a variety of services, ranging from onboarding patients, benefits investigation, prior authorization processing, appeals to the insurer, drug delivery and administration support, financial and co-pay assistance, patient education, compliance with risk evaluation and mitigation strategies, data reporting, and bridge supplies or prescription triaging.
Specialty HUB Services/Patient Assistance Providers company profiles include: background, strategy, key decision-makers, financial/investor information, solutions and services, and recent activities.
This report is available with a Single User License, a Department License (2-10 users) and a Corporate License (11+ users). View the License here. Select the appropriate License in the drop-down menu.
AMI’s Specialty HUB Services/Patient Assistance Providers 2024-2025 report includes profiles of approximately 75 companies that provide a wide range of specialty pharmaceutical hub and patient assistance services.
Specialty hub services act as a single point of contact for patients and work to make the patient’s journey easier, providing assistance with onboarding, affordability, delivery and tracking, adherence, and data reporting. Hub services vary depending on the needs of the patient.
Due to the complexity and the range of specialty drug and service offerings, the number of companies offering one or a number of hub and patient assistance services continues to increase in this highly competitive market.
As the market for digital health applications continue to grow, patients are rapidly embracing a variety of tools to take control of their health and better manage their chronic disease. New market entrants are introducing technology-based solutions focusing on a category called specialty-lite drugs in an attempt to gain a foothold in the market.
Hub and Patient Assistance Services are composed of a variety of services, ranging from onboarding patients, benefits investigation, prior authorization processing, appeals to the insurer, drug delivery and administration support, financial and co-pay assistance, patient education, compliance with risk evaluation and mitigation strategies, data reporting, and bridge supplies or prescription triaging.
As the leading source for market intelligence on hub and patient assistance service providers, AMI also offers custom research that addresses the markets’ needs, preferences and expectations, and designs projects and delivers results that helps you understand how to address the opportunity.
The report includes profiles of approximately 75 companies that include: background, strategy, key decision-makers, financial/investor information, solutions and services, and recent activities.
This report is available with a Single User License, a Department License (2-10 users) and a Corporate License (11+ users). View the License here.
Report Table of Contents
Executive Summary – pgs. 5-7
Company Profiles
| License | Corporate License, Department License, Single User |
|---|
Market Access & Distribution
BioPharma/Specialty
Market Access & Distribution
Provider Intelligence
